Report of Foreign Issuer (6-k)
May 27 2020 - 6:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE
ACT OF 1934
For the month of May 2020
Commission file number: 001-38775
ITAMAR MEDICAL LTD.
(Name of registrant)
9 Halamish Street, Caesarea 3088900,
Israel
(Address of principal executive office)
_____________________
Indicate by
check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form
40-F ¨
Indicate by check
mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check
mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
____________________
EXPLANATORY NOTE
On May 27, 2020, Itamar
Medical Ltd. issued a press release entitled "Itamar Medical Reports First Quarter 2020 Financial Results", which is
attached to this Form 6-K as Exhibit 99.1.
Exhibits
Exhibit Number
|
Description
|
99.1
|
Press Release, May 27, 2020: Itamar Medical Reports First Quarter 2020 Financial Results.
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
ITAMAR MEDICAL LTD.
|
|
|
|
|
|
By: /s/ Shy Basson
|
|
Shy Basson
Chief Financial Officer
|
Date: May 27, 2020
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Apr 2023 to Apr 2024